Olympus splits scientific solutions from medtech to create Evident subsidiary

Olympus (TYO: 7733) announced today that it has completed the separation of its Scientific Solutions Division into a wholly-owned subsidiary called Evident.

The creation of Evident — which encompasses life science research and industrial equipment — enables Olympus management to better focus on the continued growth of the company’s Medical Business, which made up 86% of revenue in the company’s 2020–21 fiscal year.

Get the full story on our sister site Massdevice. 

Read more
  • 0

These are not fireworks: The objective truth

By Jan Barghaan, Strategic Marketing Manager Life Science, Olympus Europa

No, not fireworks — it’s actually a single colony of Gloeotrichia. While this is an extreme example, can you really trust your images? The answer may depend on your objectives.

Objectives are arguably the most important microscope components; you could even think of them as the heart of the system. Not only are they responsible for primary image formation, but they have significant influence over raw image quality. When we consider that improved image quality leads to more meaningful data, the importance of quality objectives is clear.

There are three key areas to optical performance: image flatness, numerical aperture (NA), and chromatic correction. While image flatness determines the uniformity and clarity of an image throughout the field of view, NA is a measure of an objective’s ability to gather light, which improves resolution and brightness. Finally, chromatic correc…

Read more
  • 0

AI technology automates tedious cell culture work and analyses

By Joanna Hawryluk, PhD, Product Manager, Olympus Life Science

Since the early 20th century, cell culture has been considered the gold standard in various research, drug development, and diagnostic labs. Within drug discovery, cell cultures are used to develop and test compounds to determine compound efficiency and efficacy.

Before you begin growing cell cultures, you must first select the cell line that most appropriately complements the compound. The reason is that the activity may be specific to a certain cell type or protein expressed by the cells. Then you must outline the optimal conditions for both the cell culture media and the drug solvent, as well as other reagents that will be used in the process. A variation in each of these factors could affect the robustness of the downstream cell-based assay by influencing the live cells and, therefore, the assay’s results.

This brings up some important questions. How do you make sure your procedur…

Read more
  • 0